Skip to content

H. Trent Spencer

H. Trent Spencer

Company: Expression Therapeutics

Job title: President


Emerging Roles of Transgene Mutations in Gene Therapy Products for Hemophilia 9:30 am

Protein engineering strategies to increase protein expression and specific activity of Factor VIII and Factor IX proteins Immunogenicity of \variant proteins and clinical concerns How various Factor VIII mutations are moving into clinical applicationsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.